We are live on ! Find out more
PBLA

Panbela Therapeutics, Inc. Common Stock
PBLA

Delisted

PBLA was delisted on the 6th of March, 2024.

Back to rankings

10 hedge funds and large institutions have $1.72M invested in Panbela Therapeutics, Inc. Common Stock in 2021 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

17% less funds holding

Funds holding: 12 → 10 (-2)

29% less capital invested

Capital invested by funds: $2.41M → $1.72M (-$692K)

67% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 3

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
10
Holders Change
-2
Holders Change %
-16.67%
% of All Funds
0.15%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
1
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
+$46.3K

Top Sellers

Rank Fund Capital Flow
1
FPS
Fieldpoint Private Securities
Connecticut
-$92.6K
2
Millennium Management
Millennium Management
New York
-$72K
3
Goldman Sachs
Goldman Sachs
New York
-$52K
4
Citadel Advisors
Citadel Advisors
Florida
-$43K
Name Holding Trade Value Shares
Change 		Change in
Stake
IC
1
Ikarian Capital
Texas
$592K – – –
Vanguard Group
2
Vanguard Group
Pennsylvania
$396K – – –
M
3
Murchinson
Ontario, Canada
$238K – – –
FPS
4
Fieldpoint Private Securities
Connecticut
$164K -$92.6K -2 -33%
BAMG
5
Brand Asset Management Group
Missouri
$99K – – –
BFM
6
Boothbay Fund Management
New York
$60K – – –
BlackRock
7
BlackRock
New York
$52K – – –
BSW
8
Buckingham Strategic Wealth
Missouri
$43K – – –
Verition Fund Management
9
Verition Fund Management
Connecticut
$35K – – –
Morgan Stanley
10
Morgan Stanley
New York
$22K +$46.3K +1 New
TRCT
11
Tower Research Capital (TRC)
New York
$7K – – –
Osaic Holdings
12
Osaic Holdings
Arizona
$5K – – –
UBS Group
13
UBS Group
Switzerland
$5K – – –
Northwestern Mutual Wealth Management
14
Northwestern Mutual Wealth Management
Wisconsin
$1K – – –
Royal Bank of Canada
15
Royal Bank of Canada
Ontario, Canada
$1K – – –
Citadel Advisors
16
Citadel Advisors
Florida
– -$43K -1 Closed
Goldman Sachs
17
Goldman Sachs
New York
– -$52K -1 Closed
Millennium Management
18
Millennium Management
New York
– -$72K -1 Closed

PBLA Hedge Fund Activity: Q4 2021 in Review

10 of the 6,499 institutional investors tracked by Wall St. Rank reported a position in Panbela Therapeutics, Inc. Common Stock (PBLA) for Q4 2021, worth a combined $1.72M — down 29% from $2.41M a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of PBLA and 1 opened new positions — a net loss of 2 holders — while 1 trimmed existing stakes and 0 added.

The largest buyer was Morgan Stanley, opening a new position worth an estimated $46.3K. The largest seller was Fieldpoint Private Securities, cutting an estimated $92.6K.

  • 10 institutional investors held Panbela Therapeutics, Inc. Common Stock (PBLA) as of Q4 2021, down from 12 in Q3 2021.
  • Funds reported $1.72M of Panbela Therapeutics, Inc. Common Stock stock for Q4 2021, down 29% quarter-over-quarter.
  • 1 fund opened new Panbela Therapeutics, Inc. Common Stock positions in Q4 2021 and 3 closed out, a net change of -2 holders.
  • The largest Panbela Therapeutics, Inc. Common Stock buyer in Q4 2021 was Morgan Stanley, an estimated $46.3K added.
  • The largest Panbela Therapeutics, Inc. Common Stock seller in Q4 2021 was Fieldpoint Private Securities, an estimated $92.6K sold.

Based on aggregated 13F filings for Q4 2021.